GSK’s 3 billion pounds sterling peak sales goal for its multiple myeloma drug Blenrep appears increasingly attainable thanks to a key patient survival win. The antibody-drug conjugate (ADC) has ...
Pharmaceutical giant GlaxoSmithKline will pay a record $3 billion to settle U.S. regulators' criminal and civil fraud accusations over its marketing of two antidepressants and its reporting of a ...
In the largest healthcare fraud settlement in U.S. history, pharmaceutical giant GlaxoSmithKline has agreed to pay $3 billion to settle allegations that it engaged in various illegal drug marketing ...
British drugmaker GlaxoSmithKline will pay $3 billion in fines - the largest heath-care fraud settlement in U.S. history - for criminal and civil violations involving 10 drugs that are taken by ...
Drugmaker GlaxoSmithKline has agreed to a $3 billion settlement with the United States to resolve investigations of possible price irregularities and the marketing of the diabetes drug Avandia, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results